首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1757559

全球马兽医护理市场

Equine Veterinary Therapeutics

出版日期: 2025年06月27日 | 出版商:

Global Industry Analysts, Inc. | 英文 378 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球马兽医护理市场规模将达到 17 亿美元

全球马兽医治疗市场规模预计在2024年为12亿美元，预计到2030年将达到17亿美元，在2024-2030年的分析期内，复合年增长率为6.4%。抗发炎药物是本报告分析的细分市场之一，预计其复合年增长率为7.9%，到分析期结束时将达到8.441亿美元。感染疾病物细分市场在分析期间的复合年增长率预计为4.2%。

美国市场规模估计为 3.143 亿美元，中国市场预计复合年增长率为 10.4%

预计到2024年，美国马兽医治疗市场规模将达3.143亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到3.502亿美元，在2024-2030年的分析期间内，复合年增长率为10.4%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个国家的复合年增长率分别为3.1%和6.3%。在欧洲，预计德国市场的复合年增长率为4.2%。

全球马兽医护理市场—主要趋势和驱动因素摘要

临床介入的进步将如何改变马匹医疗保健？

近年来，在药理学、再生医学和精准诊断领域创新的推动下，马兽医护理领域取得了长足进展。以疼痛管理、抗寄生虫药物和抗生素为中心的传统治疗方案正迅速被旨在从细胞层面治疗慢性疾病的生物和分子疗法所补充，在某些情况下甚至被取代。特别是，骨关节炎、肌腱炎和舟骨病等肌肉骨骼疾病的治疗已从依赖皮质类固醇和非类固醇消炎剂转向依赖富血小板血浆 (PRP)、自体调理血清 (ACS) 和干细胞疗法等生物製药。

运动马和表演马中常见的呼吸系统疾病也越来越受到重视。目前，新型支气管扩张剂、黏液溶解剂和免疫调节剂正被开发用于更精准地治疗马气喘和復发性气道阻塞 (RAO)，并减少副作用。此外，荷尔蒙和代谢失衡，尤其是马METABOLIC INC.症候群 (EMS) 和脑下垂体隔膜功能障碍 (PPID)，正在采用包含长效促效剂、代谢调节剂和胰岛素增敏剂的先进配方进行治疗。这些进展正在提高饲主护理人员的依从性，并实现更持续的疾病管理。

再生医学和基因疗法在马的恢復和表现中扮演什么角色？

再生医学与马匹治疗的结合正在改变伤害恢復的轨迹，尤其对于注重持续表现的精英马术运动员而言。干细胞疗法，尤其是利用骨髓或脂肪组织来源的间质干细胞(MSC)，在肌腱损伤、软骨损伤和关节退化的治疗中正日益成为常规疗法。这些细胞具有免疫调节特性和组织特异性再生能力，可显着降低高性能马匹的再次损伤率。兽医师们也尝试使用外泌体（即富含生长因子的细胞外囊泡）来增强细胞讯号传导，促进损伤部位的癒合。

基因疗法也是一项新兴领域，但目前仍处于研究和测试阶段，无法广泛应用于马匹。实验方法包括使用病毒载体将抗发炎细胞激素和软骨保护基因直接递送至受影响的关节和组织。儘管监管和成本障碍仍然存在，但其长效甚至永久性治疗效果的潜力有可能重新定义马医学的慢性病照护。衝击波疗法、雷射疗法和脉衝电磁场疗法等补充技术也正与再生疗法结合使用，以改善疗效、缩短癒合时间并支持復健计画。这些先进的生物疗法与热感成像和超音波等改进的诊断工具相结合，可以实现更早的干预和更精确的治疗监测。

治疗通讯协定如何发展以满足特定的市场和最终用途需求？

全球马兽医治疗市场需求结构差异巨大，区域需求、马术学科和经济因素都会影响治疗方法的发展和应用。在北美和欧洲，赛马、场地障碍赛和马场马术占据着竞争的主导地位，治疗通讯协定强调合规性、反兴奋剂标准和积极的健康策略。这些地区的兽医诊所配备了影像室、内视镜和手术室，能够进行关节镜手术、整形外科固定和先进的伤口处理等复杂的干预措施。这些市场越来越重视预防性治疗以及对关节健康、代谢状态和免疫标记的纵向监测。

相反，巴西、印度和中东等新兴马匹市场正在寻求可用于赛场的经济高效的治疗方法。绞痛、寄生虫感染疾病和伤口感染疾病等常见疾病正在推动口服驱虫药、抗菌粉剂和电解质治疗的需求。然而，收入水准的提高和国际比赛参与度的提高也推动了人们对提高运动表现的药物、注射关节补充剂和赛前调理剂的兴趣。此外，治疗方法也不断发展，以满足非竞技环境中马匹的需求，例如治疗马和休閒马，在这些环境中，行为健康和慢性疼痛管理是关键问题。行为药物，尤其是抗焦虑药物和天然镇静剂，在使用马匹进行马匹辅助治疗和康復的机构中越来越受欢迎。

哪些因素推动了全球马兽医治疗市场的成长？

马兽医护理市场的成长受到多种因素的推动，这些因素反映了马匹护理的医疗化、马术运动的专业化以及马主和驯马师对马匹健康状况日益增长的期望。最突出的成长要素之一是马匹在竞技运动、治疗、休閒和礼仪用途等各个领域的应用日益广泛。一匹赛马的经济价值通常高达数十万至数百万美元，因此有必要投资先进的诊断技术、预防医学和新型疗法，以延长马匹的运动寿命并降低灾难性损伤的风险。

另一个强劲的成长催化剂是加强监管和临床基础设施建设，以支持循证兽医实践。兽医协会、製药公司和马术监管机构正在携手合作，以标准化治疗通讯协定，改善药品核准途径，并促进治疗研发创新。兽医对人类药物仿单标示外用途的接受度日益提高，加上马匹专用配方的进步，使得更广泛的治疗方法成为可能。远端医疗平台和行动兽医护理单位正在扩大农村和偏远地区的治疗覆盖面，人工智慧辅助诊断工具使从业者更容易在早期疾病升级为限制行动能力的问题之前发现并治疗它们。

此外，公众意识的提高和马主教育的加强，促使人们采取更积极主动、更预防性的马匹健康方法。饲主正在寻求第二意见，使用穿戴式感测器追踪运动异常，并希望兽医在治疗效果方面更加透明。这种行为转变推动了对各种剂型高效、快速起效且易于给药的治疗药物的需求。同时，药厂正在投资长效注射剂、偏好口服糊剂和速溶片，以提高服药顺从性和治疗效果。在高性能需求、技术创新和马科动物医学经济参与度不断增长的共同作用下，马科动物兽医治疗市场在全球范围内已准备好实现持续、多层次的成长。

部分

药物（抗发炎、抗感染疾病、抗寄生虫等）、给药途径（口服、注射、局部）、分销管道（兽医院分销管道、兽诊所分销管道、药房/药局分销管道、线上分销管道、其他分销管道）

受访企业范例（共36家）

Addison Biological Laboratory
Animart LLC
Arthrex Inc.
Aurora Pharmaceutical, Inc.
Bayer Animal Health
Bharat Serums and Vaccines Ltd.
Bimeda Inc.
Boehringer Ingelheim
Ceva Sante Animale
Covetrus Inc.
Dechra Pharmaceuticals PLC
Elanco Animal Health
Equine Products UK Ltd.
Esaote SpA
Hallmarq Veterinary Imaging
Heska Corporation
IDEXX Laboratories, Inc.
InGeneron Inc.
Kyoritsu Seiyaku Corporation
Merck Animal Health
Neogen Corporation
Norbrook Laboratories Ltd.
Panav Bio Tech
Vetoquinol SA
Virbac
WF Young, Inc.
Zoetis Inc.

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

The global market for Equine Veterinary Therapeutics estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Anti-Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$844.1 Million by the end of the analysis period. Growth in the Anti-Infective Drugs segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$314.3 Million While China is Forecast to Grow at 10.4% CAGR

The Equine Veterinary Therapeutics market in the U.S. is estimated at US$314.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$350.2 Million by the year 2030 trailing a CAGR of 10.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Equine Veterinary Therapeutics Market - Key Trends & Drivers Summarized

How Are Advancements in Clinical Interventions Transforming Equine Healthcare?

The field of equine veterinary therapeutics has advanced significantly in recent years, underpinned by innovations in pharmacology, regenerative medicine, and precision diagnostics. Traditional treatment protocols centered on pain management, antiparasitics, and antibiotics are being rapidly supplemented-and in some cases, replaced-by biologic and molecular therapies aimed at addressing chronic conditions at the cellular level. In particular, musculoskeletal disorders such as osteoarthritis, tendonitis, and navicular disease have seen a shift from reliance on corticosteroids and NSAIDs to biologics like platelet-rich plasma (PRP), autologous conditioned serum (ACS), and stem cell therapies that stimulate tissue repair and modulate inflammation more effectively over time.

Respiratory conditions, which are highly prevalent in sport and performance horses, are also receiving focused therapeutic attention. New classes of bronchodilators, mucolytics, and immunomodulators are now being tailored to manage equine asthma and recurrent airway obstruction (RAO) with greater precision and fewer side effects. Additionally, hormonal and metabolic imbalances-particularly equine metabolic syndrome (EMS) and pituitary pars intermedia dysfunction (PPID)-are being treated with advanced formulations that incorporate long-acting agonists, metabolic regulators, and insulin-sensitizing compounds. These developments are enabling more sustained disease management with improved compliance from owners and caretakers.

What Role Are Regenerative and Gene-Based Therapies Playing in Equine Recovery and Performance?

The integration of regenerative medicine into equine therapeutics is altering the trajectory of injury recovery, especially in elite equine athletes where performance longevity is critical. Stem cell therapy, particularly using mesenchymal stem cells (MSCs) derived from bone marrow or adipose tissue, is becoming increasingly routine in the treatment of tendon injuries, cartilage damage, and joint degeneration. These cells possess immunomodulatory properties and tissue-specific regenerative capabilities, significantly reducing re-injury rates in high-performance horses. Veterinary practitioners are also experimenting with exosomes and growth factor-rich extracellular vesicles to enhance cell signaling and accelerate healing at the injury site.

Gene therapy is another emerging frontier, albeit still in the research and trial phase for widespread equine use. Experimental approaches involve the use of viral vectors to deliver anti-inflammatory cytokines or cartilage-protective genes directly into affected joints or tissues. While regulatory and cost barriers persist, the potential for long-acting or even permanent therapeutic effects could redefine chronic care in equine medicine. Adjunct technologies such as shockwave therapy, laser therapy, and pulsed electromagnetic field therapy are also being used in conjunction with regenerative treatments to improve outcomes, reduce healing times, and support rehabilitation programs. The convergence of these biologically advanced therapies with improved diagnostic tools-such as thermal imaging and ultrasonography-is enabling earlier intervention and more precise treatment monitoring.

Where Are Treatment Protocols Evolving to Meet Market-Specific and End-Use Needs?

The global market for equine veterinary therapeutics is not uniform in its demand profile-regional needs, equestrian disciplines, and economic capacity all influence therapeutic development and adoption. In North America and Europe, where racing, showjumping, and dressage dominate the competitive landscape, treatment protocols are heavily aligned with regulatory compliance, anti-doping standards, and proactive wellness strategies. Veterinary hospitals in these regions are well-equipped with diagnostic imaging, endoscopy suites, and surgical units, enabling complex interventions such as arthroscopic surgery, orthopedic fixation, and advanced wound management. In these markets, there is a growing emphasis on prophylactic treatments and longitudinal monitoring of joint health, metabolic status, and immune markers.

Conversely, in emerging equine markets such as Brazil, India, and the Middle East, demand is more focused on cost-effective therapeutics that can be deployed in field settings. Common conditions such as colic, parasitic infestations, and wound infections drive demand for oral anthelmintics, antimicrobial powders, and electrolyte therapies. However, rising income levels and increased participation in international competitions are also spurring interest in performance-enhancing therapeutics, injectable joint supplements, and pre-race conditioning agents. Additionally, therapeutic approaches are evolving to meet the demands of non-competitive segments, such as therapy horses and recreational equines, where behavioral wellness and chronic pain management are critical concerns. Behavioral therapeutics-especially anxiolytics and natural calming agents-are gaining traction in facilities that use horses for equine-assisted therapy or rehabilitation.

What Forces Are Driving Growth in the Global Equine Veterinary Therapeutics Market?

The growth in the equine veterinary therapeutics market is driven by several factors that reflect the increasing medicalization of horse care, the professionalization of equestrian sports, and the rising expectations of owners and trainers regarding equine health outcomes. One of the most prominent growth drivers is the expanded use of horses across diverse sectors-including competitive sports, therapy, leisure, and ceremonial use-all of which demand tailored, high-quality therapeutic interventions. The economic value of performance horses, often running into hundreds of thousands or even millions of dollars, justifies the investment in advanced diagnostics, preventive care, and novel therapeutics that can extend performance longevity and reduce the likelihood of catastrophic injuries.

Another powerful growth catalyst is the strengthening regulatory and clinical infrastructure that supports evidence-based veterinary practice. Veterinary associations, pharmaceutical firms, and equestrian regulatory bodies are working collaboratively to standardize treatment protocols, improve drug approval pathways, and encourage innovation in therapeutic development. The growing acceptance of off-label use of human pharmaceuticals in veterinary contexts-paired with advances in equine-specific formulations-is enabling access to a broader therapeutic arsenal. Telemedicine platforms and mobile veterinary units are expanding therapeutic access to rural and remote regions, while AI-assisted diagnostic tools are making it easier for practitioners to identify and treat early-stage conditions before they escalate into performance-limiting issues.

Moreover, increased public awareness and owner education are contributing to more proactive and preventive approaches to equine health. Owners are seeking second opinions, using wearable sensors to track movement abnormalities, and demanding more transparency from veterinarians regarding treatment efficacy. These behavioral shifts are driving demand for high-efficacy, quick-onset, and easily administered therapeutics across all dosage forms. Simultaneously, pharmaceutical companies are investing in long-acting injectables, palatable oral pastes, and rapid-dissolve tablets to improve dosing compliance and treatment outcomes. With the convergence of high-performance demand, technological innovation, and growing economic participation in equine care, the equine veterinary therapeutics market is well-positioned for sustained, multi-tiered growth globally.

SCOPE OF STUDY:

The report analyzes the Equine Veterinary Therapeutics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Drugs (Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs, Other Drugs); Administration Route (Oral, Parenteral, Topical); Distribution Channel (Veterinary Hospital Distribution Channel, Veterinary Clinics Distribution Channel, Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

Addison Biological Laboratory
Animart LLC
Arthrex Inc.
Aurora Pharmaceutical, Inc.
Bayer Animal Health
Bharat Serums and Vaccines Ltd.
Bimeda Inc.
Boehringer Ingelheim
Ceva Sante Animale
Covetrus Inc.
Dechra Pharmaceuticals PLC
Elanco Animal Health
Equine Products UK Ltd.
Esaote S.p.A.
Hallmarq Veterinary Imaging
Heska Corporation
IDEXX Laboratories, Inc.
InGeneron Inc.
Kyoritsu Seiyaku Corporation
Merck Animal Health
Neogen Corporation
Norbrook Laboratories Ltd.
Panav Bio Tech
Vetoquinol S.A.
Virbac
W.F. Young, Inc.
Zoetis Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Tariff Impact on Global Supply Chain Patterns
- Equine Veterinary Therapeutics - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Prevalence of Equine Musculoskeletal and Respiratory Disorders Drives Therapeutic Product Demand
- Expansion of Equine Sports and Breeding Industries Throws Spotlight on Performance-Enhancing Treatments
- Development of Targeted Biologics and Regenerative Therapies Strengthens Business Case for Precision Veterinary Care
- Growth in Geriatric Equine Population Spurs Use of Anti-Inflammatory and Pain Management Solutions
- Increased Regulatory Approvals for Equine-Specific Pharmaceuticals Expand Therapeutic Options
- Collaboration With Academic Equine Centers Enhances R&D and Clinical Validation Pipelines
- Surge in Equine Surgery and Rehabilitation Clinics Propels Use of Post-Operative Therapeutic Protocols
- Rising Adoption of Long-Acting Injectable Formulations Improves Treatment Compliance
- Integration of Advanced Imaging and Diagnostic Tools Supports Evidence-Based Therapy Planning
- Innovation in Transdermal and Oral Delivery Methods Enhances Treatment Efficacy and Convenience
- Shift Toward Immunomodulators and Autoimmune Disease Management Fuels Development of Specialized Therapies
- Growth in Equestrian Insurance Coverage Expands Access to Advanced and Costlier Treatments
- Demand for Complementary Therapies Such as Acupuncture and Chiropractic Drives Holistic Treatment Protocols
- Development of Combination Therapies Supports Complex Multi-Symptom Management
- Global Expansion of Equine Referral Hospitals and Veterinary Networks Strengthens Distribution Reach
- Efforts to Reduce Antibiotic Overuse Encourage Development of Novel Antimicrobial Agents
- Seasonal Variation in Parasite and Infectious Disease Incidence Drives Demand for Preventive Therapeutics
- Increased Awareness of Equine Mental and Behavioral Health Spurs Demand for Anxiolytics and Mood Modulators
- Initiatives in Owner Education and Compliance Tools Enhance Long-Term Therapeutic Success
- Rising Export of High-Value Horses Encourages Use of Travel-Readiness Medications and Immune Boosters
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Equine Veterinary Therapeutics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Equine Veterinary Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 4: World 16-Year Perspective for Equine Veterinary Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 7: World 16-Year Perspective for Anti-Inflammatory Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Anti-Infective Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Anti-Infective Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 10: World 16-Year Perspective for Anti-Infective Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Parasiticides Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Parasiticides Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 13: World 16-Year Perspective for Parasiticides Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Other Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Other Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 16: World 16-Year Perspective for Other Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Pharmacies & Drug Stores Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Pharmacies & Drug Stores Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 19: World 16-Year Perspective for Pharmacies & Drug Stores Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 22: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 25: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Veterinary Hospital Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Veterinary Hospital Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 28: World 16-Year Perspective for Veterinary Hospital Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Veterinary Clinics Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Veterinary Clinics Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 31: World 16-Year Perspective for Veterinary Clinics Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 33: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 34: World 16-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 36: World Historic Review for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 37: World 16-Year Perspective for Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 38: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 39: World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 40: World 16-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 41: USA Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 42: USA Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 43: USA 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 44: USA Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 45: USA Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 46: USA 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 47: USA Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 48: USA Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 49: USA 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
CANADA
- TABLE 50: Canada Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 51: Canada Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 52: Canada 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 53: Canada Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 54: Canada Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 55: Canada 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 56: Canada Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 57: Canada Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 58: Canada 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
JAPAN
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 59: Japan Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 60: Japan Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 61: Japan 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 62: Japan Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 63: Japan Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 64: Japan 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 65: Japan Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 66: Japan Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 67: Japan 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
CHINA
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 68: China Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 69: China Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 70: China 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 71: China Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 72: China Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 73: China 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 74: China Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 75: China Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 76: China 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
EUROPE
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 77: Europe Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 78: Europe Historic Review for Equine Veterinary Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 79: Europe 16-Year Perspective for Equine Veterinary Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
- TABLE 80: Europe Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 81: Europe Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 82: Europe 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 83: Europe Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 84: Europe Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 85: Europe 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 86: Europe Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 87: Europe Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 88: Europe 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
FRANCE
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 89: France Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 90: France Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 91: France 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 92: France Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 93: France Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 94: France 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 95: France Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 96: France Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 97: France 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
GERMANY
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 98: Germany Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 99: Germany Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 100: Germany 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 101: Germany Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 102: Germany Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 103: Germany 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 104: Germany Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 105: Germany Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 106: Germany 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
ITALY
- TABLE 107: Italy Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 108: Italy Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 109: Italy 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 110: Italy Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 111: Italy Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 112: Italy 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 113: Italy Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 114: Italy Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 115: Italy 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
UNITED KINGDOM
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 116: UK Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 117: UK Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 118: UK 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 119: UK Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 120: UK Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 121: UK 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 122: UK Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 123: UK Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 124: UK 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
SPAIN
- TABLE 125: Spain Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 126: Spain Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 127: Spain 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 128: Spain Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 129: Spain Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 130: Spain 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 131: Spain Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 132: Spain Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 133: Spain 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
RUSSIA
- TABLE 134: Russia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 135: Russia Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 136: Russia 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 137: Russia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 138: Russia Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 139: Russia 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 140: Russia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 141: Russia Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 142: Russia 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
REST OF EUROPE
- TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 144: Rest of Europe Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 145: Rest of Europe 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 147: Rest of Europe Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 148: Rest of Europe 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 150: Rest of Europe Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 151: Rest of Europe 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
ASIA-PACIFIC
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 153: Asia-Pacific Historic Review for Equine Veterinary Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 154: Asia-Pacific 16-Year Perspective for Equine Veterinary Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
- TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 156: Asia-Pacific Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 157: Asia-Pacific 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 159: Asia-Pacific Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 160: Asia-Pacific 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 162: Asia-Pacific Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 163: Asia-Pacific 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
AUSTRALIA
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 164: Australia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 165: Australia Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 166: Australia 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 167: Australia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 168: Australia Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 169: Australia 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 170: Australia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 171: Australia Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 172: Australia 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
INDIA
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 173: India Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 174: India Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 175: India 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 176: India Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 177: India Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 178: India 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 179: India Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 180: India Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 181: India 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
SOUTH KOREA
- TABLE 182: South Korea Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 183: South Korea Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 184: South Korea 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 185: South Korea Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 186: South Korea Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 187: South Korea 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 188: South Korea Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 189: South Korea Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 190: South Korea 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 192: Rest of Asia-Pacific Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 195: Rest of Asia-Pacific Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 198: Rest of Asia-Pacific Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
LATIN AMERICA
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 200: Latin America Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 201: Latin America Historic Review for Equine Veterinary Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 202: Latin America 16-Year Perspective for Equine Veterinary Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
- TABLE 203: Latin America Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 204: Latin America Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 205: Latin America 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 206: Latin America Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 207: Latin America Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 208: Latin America 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 209: Latin America Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 210: Latin America Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 211: Latin America 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
ARGENTINA
- TABLE 212: Argentina Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 213: Argentina Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 214: Argentina 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 215: Argentina Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 216: Argentina Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 217: Argentina 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 218: Argentina Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 219: Argentina Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 220: Argentina 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
BRAZIL
- TABLE 221: Brazil Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 222: Brazil Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 223: Brazil 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 224: Brazil Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 225: Brazil Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 226: Brazil 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 227: Brazil Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 228: Brazil Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 229: Brazil 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
MEXICO
- TABLE 230: Mexico Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 231: Mexico Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 232: Mexico 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 233: Mexico Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 234: Mexico Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 235: Mexico 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 236: Mexico Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 237: Mexico Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 238: Mexico 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 240: Rest of Latin America Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 241: Rest of Latin America 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 243: Rest of Latin America Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 244: Rest of Latin America 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 246: Rest of Latin America Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 247: Rest of Latin America 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
MIDDLE EAST
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 248: Middle East Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 249: Middle East Historic Review for Equine Veterinary Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 250: Middle East 16-Year Perspective for Equine Veterinary Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
- TABLE 251: Middle East Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 252: Middle East Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 253: Middle East 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 254: Middle East Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 255: Middle East Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 256: Middle East 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 257: Middle East Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 258: Middle East Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 259: Middle East 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
IRAN
- TABLE 260: Iran Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 261: Iran Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 262: Iran 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 263: Iran Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 264: Iran Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 265: Iran 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 266: Iran Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 267: Iran Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 268: Iran 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
ISRAEL
- TABLE 269: Israel Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 270: Israel Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 271: Israel 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 272: Israel Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 273: Israel Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 274: Israel 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 275: Israel Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 276: Israel Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 277: Israel 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
SAUDI ARABIA
- TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 279: Saudi Arabia Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 280: Saudi Arabia 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 282: Saudi Arabia Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 283: Saudi Arabia 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 285: Saudi Arabia Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 286: Saudi Arabia 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
UNITED ARAB EMIRATES
- TABLE 287: UAE Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 288: UAE Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 289: UAE 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 290: UAE Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 291: UAE Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 292: UAE 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 293: UAE Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 294: UAE Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 295: UAE 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
REST OF MIDDLE EAST
- TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 297: Rest of Middle East Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 298: Rest of Middle East 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 300: Rest of Middle East Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 301: Rest of Middle East 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 303: Rest of Middle East Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 304: Rest of Middle East 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
AFRICA
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 305: Africa Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 306: Africa Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 307: Africa 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 308: Africa Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 309: Africa Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 310: Africa 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 311: Africa Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 312: Africa Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 313: Africa 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030